Operating Activities: | |
Net income | |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation and amortization | |
Amortization of debt issuance costs | |
Amortization of debt discount | |
Deferred income taxes | -21.84M |
Stock-based compensation expense | |
Gain on sale of property, buildings and equipment | |
Asset impairment charge | |
Equity income, net of distributions of $1,864 | |
Excess tax benefit from stock-based compensation | |
Interest related to uncertain tax positions | |
Changes in assets and liabilities | |
Trade and other receivables, net | -15.52M |
Inventories, net | -7.65M |
Prepaid expenses and other current assets | -8.63M |
Accounts payable | -30.29M |
Accrued payroll and benefit costs | -2.65M |
Other current and noncurrent liabilities | 37M |
Net cash provided by operating activities | 217.19M |
Investing Activities: | |
Capital expenditures | -13.18M |
Acquisition payments | |
Proceeds from sale of subsidiary | |
Equity distribution | |
Collection of note receivable | |
Proceeds from sale of assets | |
Net cash (used) provided by investing activities | -67.81M |
Financing Activities: | |
Proceeds from issuance of long-term debt | 1.73B |
Repayments of long-term debt | -1.92B |
Debt issuance costs | |
Proceeds from the exercise of stock options | |
Excess tax benefit from stock-based compensation | |
Purchases of common stock | -4.07M |
Increase (decrease) in bank overdrafts | |
Payments on capital lease obligations | |
Net cash (used) provided by financing activities | -198.09M |
Effect of exchange rate changes on cash and cash equivalents | 1.27M |
Net change in cash and cash equivalents | -47.44M |
Cash and cash equivalents at the beginning of period | 160.28M |
Cash and cash equivalents at the end of period | 112.84M |
Non-cash investing and financing activities: | |
Property, buildings and equipment acquired through capital leases | |
Issuance of treasury stock |